KoBioLabs

Category:
Main Business Area

New drugs

Wishlist

This company focuses on the development of new drugs, particularly in the areas of immunity, metabolism, and neurological disorders. Their pipeline includes drugs like KBL-697 and KBL-693, which are in Phase 2 and Phase 1 clinical trials respectively.

Find out more companies